BIOMARIN PHARMACEUTICAL INC (BMRN): SEC Filings & AI Analysis

Healthcare. Latest 10-K, 10-Q, and 8-K filings for BIOMARIN PHARMACEUTICAL INC (BMRN) with AI risk scoring and cited answers, grounded in primary-source SEC EDGAR data.

Most recent filing — 10-Q filed November 3, 2026: BEARISH Concern level: HIGH.

Company overview — key questions

Answers are generated from SEC filings and StockHuntr's analysis. Not investment advice.

What is BIOMARIN PHARMACEUTICAL INC (BMRN)?

BIOMARIN PHARMACEUTICAL INC is a publicly traded company in the Healthcare space tracked on StockHuntr, which analyzes its SEC filings (10-K, 10-Q, 8-K) and generates 30-day stock predictions.

What are BMRN's most recent SEC filings?

Recent filings: 10-Q (November 3, 2026), 8-K (November 2, 2026), 8-K (October 6, 2026), 8-K (September 30, 2026), 8-K (September 15, 2026).

What does BMRN's latest filing analysis show?

BMRN's most recent 10-Q (November 3, 2026) is rated BEARISH, concern level HIGH.

What is the 30-day outlook for BMRN?

Based on BMRN's latest filing, the model projects it will perform roughly in line with the S&P 500 over the next 30 days. This is model analysis for research, not investment advice.

Is BMRN a buy?

StockHuntr doesn't issue buy or sell ratings — it's a research tool. For BIOMARIN PHARMACEUTICAL INC (BMRN), its latest 10-Q is rated HIGH concern and the model projects it will perform roughly in line with the S&P 500 over 30 days. Weigh these filing-based signals alongside your own research. This is model analysis for research, not investment advice.

Recent BMRN filings analyzed

  • 10-Q · Nov 3, 2026 · concern 7.2/10
  • 8-K · Nov 2, 2026 · concern 5.8/10
  • 8-K · Oct 6, 2026 · concern 7.2/10
  • 8-K · Sep 30, 2026 · concern 2.1/10
  • 8-K · Sep 15, 2026 · concern 6.8/10

Other Healthcare companies

About this analysis

Additional data:
Yahoo Finance (market data)
Method:
StockHuntr analyzes filings with AI — see our methodology.
Analysis as of:
November 3, 2026
Published by:
StockHuntr

For research and education only. Nothing here is investment advice.

Loading BMRN snapshot...

Fetching live market data